Lower Cumulative Incidence of Relapse but Higher Incidence of NRM in Patients with Poor Graft Function Following Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Prabahran, Ashvind [1 ,2 ,3 ,4 ]
Koldej, Rachel [1 ,2 ]
Chee, Lynette C. Y. [1 ,2 ,4 ,5 ]
Ritchie, David S. [1 ,2 ,4 ,5 ]
机构：
[1] Royal Melbourne Hosp, ACRF Lab, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Med, Parkville, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Clin Haematol & Bone Marrow Transplantat, Melbourne, Australia
[4] Royal Melbourne Hosp, Melbourne, Vic, Australia
[5] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] THE INCIDENCE, RISK FACTORS AND OUTCOME OF POOR GRAFT FUNCTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Sun, Y.
    Xu, L.
    Liu, D.
    Liu, K.
    Huang, X.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S478 - S478
  • [2] Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
    H Alchalby
    D-R Yunus
    T Zabelina
    F Ayuk
    N Kröger
    Bone Marrow Transplantation, 2016, 51 : 1223 - 1227
  • [3] Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
    Alchalby, H.
    Yunus, D-R
    Zabelina, T.
    Ayuk, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2016, 51 (09) : 1223 - 1227
  • [4] Immunologic Basis to Poor Graft Function Following Allogeneic Stem Cell Transplantation
    Prabahran, Ashvind Anand
    Koldej, Rachel M.
    Chee, Lynette C. Y.
    Ritchie, David
    BLOOD, 2022, 140 : 10453 - 10454
  • [5] The incidence, risk factors and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    Zhao, Yanmin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 249 - 250
  • [6] Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Zhao, Yanmin
    Gao, Fei
    Shi, Jimin
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Yu, Jian
    Huang, He
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1898 - 1907
  • [7] The economic cost of care in poor graft function following allogeneic stem cell transplantation
    Juneja, Manu
    Prabahran, Ashvind
    Rawicki, Mayani
    Chee, Lynette C. Y.
    Koldej, Rachel M.
    Ritchie, David S.
    BONE MARROW TRANSPLANTATION, 2025, 60 (01) : 97 - 99
  • [8] Incidence of late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
    Atagunduz, Isik Kaygusuz
    Badbaran, Anita
    Zeck, Gaby
    Wolschke, Christine
    Ayuk, Francis
    Christopeit, Maximilian
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 274 - 274
  • [9] Impact of CD3+cell dose in the graft on cumulative incidence of relapse after allogeneic stem cell transplantation in children and adolescents with acute leukemia
    Prudnikau, D.
    Isaykina, Y.
    Barouskaya, J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S133 - S133
  • [10] Impact of different methods of T-cell depletion on poor graft function incidence after allogeneic hematopoietic stem cell transplantation
    Levrat, S. Masouridi
    Simonetta, F.
    Tirefort, Y.
    Tsopra, O.
    Dantin, C.
    Beauverd, Y.
    Simon, A.
    Polchlopeck, K.
    Stephan, C.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S429 - S430
12345